134 related articles for article (PubMed ID: 1081934)
1. Serum lymphocytotoxins in inflammatory bowel disease. Studies of frequency and specificity for lymphocyte subpopulations.
Strickland RG; Friedler EM; Henderson CA; Wilson ID; Williams RD
Clin Exp Immunol; 1975 Sep; 21(3):384-93. PubMed ID: 1081934
[TBL] [Abstract][Full Text] [Related]
2. Ulcerative colitis in a patient with anti-B lymphocytotoxin and hypogammaglobulinemia.
Matuchansky C; Messing B; Tursz T; Galian A; Bernier JJ; Seligmann M; Preud'homme JL
Gastroenterology; 1977 Sep; 73(3):578-82. PubMed ID: 330304
[TBL] [Abstract][Full Text] [Related]
3. Cold-reactive lymphocytotoxins in Crohn's disease and ulcerative colitis. I. Incidence and characterization.
Brown DJ; Jewell DP
Clin Exp Immunol; 1982 Jul; 49(1):67-74. PubMed ID: 6982133
[TBL] [Abstract][Full Text] [Related]
4. Peripheral blood mononuclear cells from patients with inflammatory bowel disease exhibit normal function in the allogeneic and autologous mixed leukocyte reaction and cell-mediated lympholysis.
MacDermott RP; Bragdon MJ; Thurmond RD
Gastroenterology; 1984 Mar; 86(3):476-84. PubMed ID: 6229444
[TBL] [Abstract][Full Text] [Related]
5. Lymphocytotoxins in acute and chronic hepatitis. Characterization and relationship to changes in circulating T lymphocytes.
Dehoratius RJ; Henderson C; Strickland RG
Clin Exp Immunol; 1976 Oct; 26(1):21-7. PubMed ID: 1087213
[TBL] [Abstract][Full Text] [Related]
6. Lymphocyte subpopulations in Crohn's disease and chronic ulcerative colitis.
Sorensen SF; Hoj L
Acta Pathol Microbiol Scand C; 1977 Feb; 85(1):41-8. PubMed ID: 320824
[TBL] [Abstract][Full Text] [Related]
7. Alteration in T lymphocyte subpopulations in inflammatory bowel disease.
Victorino RM; Hodgson HJ
Clin Exp Immunol; 1980 Jul; 41(1):156-65. PubMed ID: 6969150
[TBL] [Abstract][Full Text] [Related]
8. Serum lymphocytotoxic and lymphocytophilic antibody activity in inflammatory bowel disease.
Korsmeyer S; Strickland RG; Wilson ID; Williams RC
Gastroenterology; 1974 Oct; 67(4):578-83. PubMed ID: 4607065
[No Abstract] [Full Text] [Related]
9. In vitro testing of immunoresponsiveness in patients with inflammatory bowel disease: prevalence and relationship to disease activity immunoresponsiveness in IBD.
Lyanga JJ; Davis P; Thomson AB
Clin Exp Immunol; 1979 Jul; 37(1):120-5. PubMed ID: 314871
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal B lymphocytes in the peripheral blood of patients with inflammatory bowel disease.
Ginsburg CH; Ault KA; Falchuk ZM
Gastroenterology; 1981 Dec; 81(6):1111-4. PubMed ID: 7026345
[TBL] [Abstract][Full Text] [Related]
11. T-cell immunoregulation in patients with inflammatory bowel disease. II. Enhanced suppressor T-cell activity in ulcerative colitis.
Kramer JK; Depew WT; Szewczuk MR
J Clin Lab Immunol; 1988 Jan; 25(1):19-27. PubMed ID: 2968458
[TBL] [Abstract][Full Text] [Related]
12. [Immunohistological study of T-lymphocytes (total and helper) and B-lymphocytes of the colonic mucosa in children with Crohn's disease and non-specific ulcerative colitis].
Rodrigues M; Zerbini MC; Barbieri D
Arq Gastroenterol; 1998; 35(3):223-36. PubMed ID: 10029869
[TBL] [Abstract][Full Text] [Related]
13. Elevated numbers of peripheral T cells in inflammatory bowel diseases displaying T9 antigen and Fc alpha receptors.
Raedler A; Fraenkel S; Klose G; Thiele HG
Clin Exp Immunol; 1985 Jun; 60(3):518-24. PubMed ID: 2990780
[TBL] [Abstract][Full Text] [Related]
14. Pokeweed mitogen stimulated immunoglobulin production by peripheral blood lymphocytes in vitro: evidence for disordered immunoregulation in patients with ulcerative colitis and Crohn's disease.
Danis VA; Heatley RV
Clin Exp Immunol; 1983 Dec; 54(3):739-46. PubMed ID: 6606515
[TBL] [Abstract][Full Text] [Related]
15. T-cell immunoregulation in patients with inflammatory bowel disease. I. Differential helper T-cell function in ulcerative colitis and Crohn's disease.
Kramer JK; Depew WT; Szewczuk MR
J Clin Lab Immunol; 1988 Jan; 25(1):9-17. PubMed ID: 2968459
[TBL] [Abstract][Full Text] [Related]
16. The subpopulations of circulating white blood cells in inflammatory bowel disease.
Thayer WR; Charland C; Field CE
Gastroenterology; 1976 Sep; 71(3):379-84. PubMed ID: 1084844
[TBL] [Abstract][Full Text] [Related]
17. Immunoglobulin M memory B cell decrease in inflammatory bowel disease.
Di Sabatino A; Carsetti R; Rosado MM; Ciccocioppo R; Cazzola P; Morera R; Tinozzi FP; Tinozzi S; Corazza GR
Eur Rev Med Pharmacol Sci; 2004; 8(5):199-203. PubMed ID: 15638230
[TBL] [Abstract][Full Text] [Related]
18. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5.
Fuss IJ; Neurath M; Boirivant M; Klein JS; de la Motte C; Strong SA; Fiocchi C; Strober W
J Immunol; 1996 Aug; 157(3):1261-70. PubMed ID: 8757634
[TBL] [Abstract][Full Text] [Related]
19. Lymphocytotoxins in vasculitis. Correlation with clinical manifestations and laboratory variables.
Pruzanski W; Sarraf D; Klein M; Lau CY; Richardson JE; Keystone EC
J Rheumatol; 1986 Dec; 13(6):1066-71. PubMed ID: 2882024
[TBL] [Abstract][Full Text] [Related]
20. Expression of CD45RB functionally distinguishes intestinal T lymphocytes in inflammatory bowel disease.
Ten Hove T; The Olle F; Berkhout M; Bruggeman JP; Vyth-Dreese FA; Slors JF; Van Deventer SJ; Te Velde AA
J Leukoc Biol; 2004 Jun; 75(6):1010-5. PubMed ID: 15020649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
